ADVANCED ENZYME TECH LTD (ADVENZYMES) financials

ADVANCED ENZYME TECH LTD (ADVENZYMES) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Market Cap: ₹2,990Cr.
Current Price: ₹267
Stock P/E: 36.1
ROE: 20.2%
ROCE: 24.1%
Book Value: ₹63.4
Dividend Yield: 2.00%
52W High / Low: ₹420/252

In Jun 2026, ADVANCED ENZYME TECH LTD (ADVENZYMES) reported sales ₹116 Cr and net profit ₹22 Cr.

Annual TTM: sales ₹444 Cr, net profit ₹80 Cr.

Shareholding: Promoters 43.56% (Sep 2026), FIIs 26.64% (Sep 2026), DIIs 1.89% (Sep 2026), Public 27.90% (Sep 2026), No. of Shareholders 67,468% (Sep 2026).

ADVENZYMES quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	77	101	87	125	116	96	116	116
Expenses	64	79	73	94	86	72	90	85
Operating Profit	14	22	14	31	30	23	27	30
OPM %	17%	22%	16%	24%	26%	25%	23%	26%
Other Income	2	1	5	54	3	-3	5	2
Interest	0	0	0	0	0	0	0	0
Depreciation	3	3	3	3	3	3	3	3
Profit before tax	12	21	16	81	30	18	29	30
Tax %	26%	26%	29%	9%	25%	26%	23%	25%
Net Profit	9	15	11	74	22	13	22	22
EPS in Rs	0.82	1.36	0.99	6.61	1.99	1.18	1.99	2.00
Raw PDF	—	—	—	—	—	—	—	—

ADVENZYMES profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	247	283	273	312	365	351	453	444
Expenses	170	183	200	236	260	280	342	333
Operating Profit	77	101	73	76	105	71	111	110
OPM %	31%	36%	27%	24%	29%	20%	24%	25%
Other Income	9	7	9	9	40	61	60	8
Interest	1	0	0	0	0	1	0	0
Depreciation	9	9	10	10	11	11	12	12
Profit before tax	76	98	72	74	134	121	158	106
Tax %	24%	28%	24%	25%	19%	15%	16%	—
Net Profit	58	71	55	56	108	102	132	80
EPS in Rs	5.19	6.36	4.88	4.97	9.67	9.15	11.78	7.16
Dividend Payout %	12%	14%	21%	20%	53%	57%	45%	—

ADVENZYMES balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	22	22	22	22	22	22	22	22
Reserves	297	348	413	458	503	558	607	687
Borrowings	18	10	1	2	2	2	3	2
Other Liabilities	38	42	53	48	48	51	57	92
Total Liabilities	376	423	489	530	576	633	689	804
Fixed Assets	97	127	131	132	143	142	156	151
CWIP	7	10	7	9	11	22	21	49
Investments	120	121	184	189	201	256	290	345
Other Assets	151	165	166	200	220	213	221	259
Total Assets	376	423	489	530	576	633	689	804

ADVENZYMES cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	35	46	84	37	50	52	63	89
Cash from Investing Activity	-2	-25	-70	-14	-42	-3	-2	-34
Cash from Financing Activity	-33	-19	-15	-11	-12	-57	-58	-58
Net Cash Flow	0	2	-1	12	-4	-8	4	-4
Free Cash Flow	32	5	75	28	27	31	41	44
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	90%	76%	110%	80%	88%	75%	120%	105%

ADVENZYMES shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	42.92%	43.08%	43.08%	43.08%	43.04%	43.26%	43.25%	43.56%
FIIs	12.57%	11.90%	23.45%	25.41%	25.85%	25.50%	26.70%	26.64%
DIIs	8.17%	8.19%	8.45%	6.41%	5.51%	5.41%	4.77%	1.89%
Public	36.31%	36.82%	25.00%	25.09%	25.62%	25.85%	25.28%	27.90%
No. of Shareholders	67,351	65,322	67,589	69,637	68,051	66,193	63,599	67,468

ADVENZYMES key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	63	77	70	66	78	75	81	76
Inventory Days	249	245	240	295	228	268	260	230
Days Payable	66	56	85	75	54	60	64	101
Cash Conversion Cycle	246	265	226	286	252	283	277	205
Working Capital Days	93	126	109	141	131	155	151	117
ROCE %	15%	21%	24%	16%	15%	28%	20%	24%

ADVENZYMESUpdated 18 Oct 2026, 5:02

Advanced Enzyme Tech Ltd

ADVENZYMESUpdated 18 Oct 2026, 5:02

Market Cap

₹2,990Cr.

Current Price

₹267

High / Low

₹420/252

Stock P/E

36.1

ROE20.2%

ROCE24.1%

Book Value₹63.4

Face Value₹2.00

Dividend Yield2.00%

About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	85	61	51	3	73	8	67	6.04
Sep 2023	97	70	1	3	25	26	18	1.64
Dec 2023	91	67	4	3	25	25	19	1.71
Mar 2024	92	63	-16	3	10	70	3	0.28
Jun 2024	86	65	54	3	72	7	67	6
Sep 2024	77	64	2	3	12	26	9	0.82
Dec 2024	101	79	1	3	21	26	15	1.36
Mar 2025	87	73	5	3	16	29	11	0.99
Jun 2025	125	94	54	3	81	9	74	6.61
Sep 2025	116	86	3	3	30	25	22	1.99
Dec 2025	96	72	-3	3	18	26	13	1.18
Mar 2026	116	90	5	3	29	23	22	1.99
Jun 2026	116	85	2	3	30	25	22	2

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	125	5	91	1	8	23	14	20	1.81
Mar 2016	139	4	103	1	7	25	18	21	1.92
Mar 2017	173	3	124	6	8	44	21	35	3.1
Mar 2018	212	3	162	5	8	44	18	36	3.22
Mar 2019	222	3	169	6	9	47	25	35	3.16
Mar 2020	247	1	170	9	9	76	24	58	5.19
Mar 2021	283	0	183	7	9	98	28	71	6.36
Mar 2022	273	0	200	9	10	72	24	55	4.88
Mar 2023	312	0	236	9	10	74	25	56	4.97
Mar 2024	365	0	260	40	11	134	19	108	9.67
Mar 2025	351	1	280	61	11	121	15	102	9.15
Mar 2026	453	0	342	60	12	158	16	132	11.78
TTM	444	0	333	8	12	106	—	80	7.16

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	43.56%
FIIs	26.64%
DIIs	1.89%
Public	27.9%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	43.62%	22.54%	6.98%	26.88%
Mar 2024	43.5%	23.01%	7.56%	25.95%
Jun 2024	43.02%	12.03%	8.08%	36.87%
Sep 2024	42.95%	12.63%	8.02%	36.4%
Dec 2024	42.92%	12.57%	8.17%	36.31%
Mar 2025	43.08%	11.9%	8.19%	36.82%
Jun 2025	43.08%	23.45%	8.45%	25%
Sep 2025	43.08%	25.41%	6.41%	25.09%
Dec 2025	43.04%	25.85%	5.51%	25.62%
Mar 2026	43.26%	25.5%	5.41%	25.85%
Jun 2026	43.25%	26.7%	4.77%	25.28%
Sep 2026	43.56%	26.64%	1.89%	27.9%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	22	134	38	28	223	106	5	27	84	223
Mar 2016	22	152	49	37	261	101	7	53	99	261
Mar 2017	22	233	38	25	318	98	8	103	108	318
Mar 2018	22	267	45	39	373	98	10	120	145	373
Mar 2019	22	297	18	38	376	97	7	120	151	376
Mar 2020	22	348	10	42	423	127	10	121	165	423
Mar 2021	22	413	1	53	489	131	7	184	166	489
Mar 2022	22	458	2	48	530	132	9	189	200	530
Mar 2023	22	503	2	48	576	143	11	201	220	576
Mar 2024	22	558	2	51	633	142	22	256	213	633
Mar 2025	22	607	3	57	689	156	21	290	221	689
Mar 2026	22	687	2	92	804	151	49	345	259	804

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	33	-7	-27	-1
Mar 2016	22	-27	4	0
Mar 2017	21	-55	34	0
Mar 2018	23	-22	-1	0
Mar 2019	35	-2	-33	0
Mar 2020	46	-25	-19	2
Mar 2021	84	-70	-15	-1
Mar 2022	37	-14	-11	12
Mar 2023	50	-42	-12	-4
Mar 2024	52	-3	-57	-8
Mar 2025	63	-2	-58	4
Mar 2026	89	-34	-58	-4

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	71	60	65	66	63	77	70	66	78	75	81	76
Inventory Days	389	393	300	234	249	245	240	295	228	268	260	230
Days Payable	74	75	50	90	66	56	85	75	54	60	64	101
Cash Conversion Cycle	386	378	316	210	246	265	226	286	252	283	277	205
Working Capital Days	61	65	108	58	93	126	109	141	131	155	151	117
ROCE %	14%	14%	18%	15%	15%	21%	24%	16%	15%	28%	20%	24%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ADVANCED ENZYME TECH LTD (ADVENZYMES)?

The reported market capitalisation for ADVANCED ENZYME TECH LTD (ADVENZYMES) is ₹2,990Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ADVENZYMES?

The current price shown for ADVANCED ENZYME TECH LTD (ADVENZYMES) on Fincrux is ₹267 with a 52-week high/low of ₹420/252.

What is the P/E ratio of ADVANCED ENZYME TECH LTD (ADVENZYMES)?

The stock P/E for ADVANCED ENZYME TECH LTD (ADVENZYMES) is 36.1 on Fincrux, with ROE at 20.2% and ROCE at 24.1%.

What were ADVENZYMES latest quarterly results?

For Jun 2026, ADVANCED ENZYME TECH LTD (ADVENZYMES) reported sales ₹116 Cr and net profit ₹22 Cr (figures in ₹ crore unless noted).

What are ADVENZYMES annual sales and net profit?

For TTM, ADVANCED ENZYME TECH LTD (ADVENZYMES) shows sales of ₹444 Cr and net profit of ₹80 Cr on the Fincrux profit & loss statement.

Who owns ADVANCED ENZYME TECH LTD (ADVENZYMES)?

Latest shareholding for ADVANCED ENZYME TECH LTD (ADVENZYMES) on Fincrux: Promoters 43.56% (Sep 2026), FIIs 26.64% (Sep 2026), DIIs 1.89% (Sep 2026), Public 27.90% (Sep 2026), No. of Shareholders 67,468% (Sep 2026).

Where can I find ADVANCED ENZYME TECH LTD (ADVENZYMES) financials?

ADVANCED ENZYME TECH LTD (ADVENZYMES) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ADVENZYMES balance sheet and cash flow?

Yes. The ADVANCED ENZYME TECH LTD (ADVENZYMES) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:02